IRAK-4 inhibitors (Baltimore VA Medical)

N/A

Report date: 2025/03/20 15:05:40
NME

Base Information

Drug NameIRAK-4 inhibitors (Baltimore VA Medical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaltimore Va Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesBaltimore Va Medical Center
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A